Stock ELEV ELEVATION ONCOLOGY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Elevation Oncology, Inc.

Equities

ELEV

US28623U1016

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
4.02 USD -1.23% Intraday chart for Elevation Oncology, Inc. +4.69% +648.60%
May. 31 Piper Sandler Starts Elevation Oncology With Overweight Rating, $10 Price Target MT
May. 14 Stephens Starts Elevation Oncology With Overweight Rating, $8 Price Target MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
ELEVATION ONCOLOGY, INC. Stock Elevation Oncology, Inc.
 220M - - - - -
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 24.28B -
ARGENX SE Stock argenx SE
 21.96B -
GENMAB A/S Stock Genmab A/S
 18.16B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
 16.37B
  1. Stock Market
  2. Equities
  3. ELEV Stock
  4. Charts Elevation Oncology, Inc.
  5. Sector Chart